Clinical trial
Continuous Infusion of Terlipressin in Septic Shock
NCT00481572 · University of Roma La Sapienza, Other · Completed
Key facts
| NCT number | NCT00481572 |
|---|---|
| Title | Continuous Infusion of Terlipressin in Septic Shock |
| Official title | Continuous Terlipressin Versus Vasopressin Infusion in Septic Shock. A Randomized, Controlled, Pilot Trial. "THE TERLIVAP STUDY" |
| Lead sponsor | University of Roma La Sapienza, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Septic Shock |
| Intervention type | Drug |
| Interventions | Terlipressin, Vasopressin, Norepinephrine |
| Enrollment | 45 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jun 1, 2007 |
| Last update posted | Feb 29, 2008 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: